EMA Decision Time For Aztreonam-Avibactam; High-Stakes Meeting For Lecanamab
The European Medicines Agency is this week deciding whether a number of new drugs should win EU approval.
The European Medicines Agency is this week deciding whether a number of new drugs should win EU approval.